Page last updated: 2024-10-31

mitotane and Adrenogenital Syndrome

mitotane has been researched along with Adrenogenital Syndrome in 1 studies

Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.

Adrenogenital Syndrome: Abnormal SEX DIFFERENTIATION or congenital DISORDERS OF SEX DEVELOPMENT caused by abnormal levels of steroid hormones expressed by the GONADS or the ADRENAL GLANDS, such as in CONGENITAL ADRENAL HYPERPLASIA and ADRENAL CORTEX NEOPLASMS. Due to abnormal steroid biosynthesis, clinical features include VIRILISM in females; FEMINIZATION in males; or precocious sexual development in children.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
NETTO, AD1
WAJCHENBERG, BL1
RAVAGLIA, C1
PEREIRA, VG1
SHNAIDER, J1
PUPO, AA1
CINTRA, AB1

Other Studies

1 other study available for mitotane and Adrenogenital Syndrome

ArticleYear
TREATMENT OF ADRENOCORTICAL CANCER WITH O,P'-DDD.
    Annals of internal medicine, 1963, Volume: 59

    Topics: Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenogenital Syndrome; Antineoplastic Agents; Ca

1963